CIK 0001061983 · Large accelerated filer
CYTOKINETICS INC
Sign in to watch- Ticker
- CYTK
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 943291317
- Phone
- (650) 624-3000
- Business address
- 350 OYSTER POINT BOULEVARD, ., SOUTH SAN FRANCISCO, CA, 94080
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $12,208,275
- in 16 filings, $12.2M under 10b5-1 plans
Net −$12,208,275. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-04-15 | HENDERSON JOHN T Director | Option exercise · Stock Option (Right to Buy) 10b5-1 | −20,000 | 0 | ||
| 2025-04-15 | HENDERSON JOHN T Director | Grant or award | +551 | $38.56 | $21K | 66,348 |
| 2025-04-15 | Harrington Robert Arthur Director | Grant or award | +324 | $38.56 | $12K | 14,982 |
| 2025-04-15 | Kaye Edward M. MD Director | Grant or award | +324 | $38.56 | $12K | 25,961 |
| 2025-04-15 | WIERENGA WENDALL Director | Grant or award | +162 | $38.56 | $6K | 24,848 |
| 2025-04-15 | Wysenski Nancy Director | Grant or award | +162 | $38.56 | $6K | 23,277 |
| 2025-04-10 | Blum Robert I President & CEO | Sale 10b5-1 | −5,000 | $36.77 | $184K | 422,629 |
| 2025-04-08 | Malik Fady Ibraham EVP Research & Development | Option exercise 10b5-1 | +2,000 | $10.60 | $21K | 142,255 |
| 2025-04-08 | Malik Fady Ibraham EVP Research & Development | Sale 10b5-1 | −2,000 | $36.18 | $72K | 140,255 |
| 2025-04-08 | Malik Fady Ibraham EVP Research & Development | Option exercise · Non-Qualified Stock Option (Right to Buy) 10b5-1 | −2,000 | 27,105 | ||
| 2025-04-07 | Callos Andrew EVP, Chief Commercial Officer | Sale 10b5-1 | −2,886 | $35.78 | $103K | 64,689 |
| 2025-04-03 | Harrington Robert Arthur Director | Sale 10b5-1 | −450 | $39.43 | $18K | 14,658 |
| 2025-03-31 | Blum Robert I President & CEO | Sale 10b5-1 | −15,000 | $40.75 | $611K | 427,629 |
| 2025-03-19 | Malik Fady Ibraham EVP Research & Development | Gift | −200 | 140,255 | ||
| 2025-03-18 | Malik Fady Ibraham EVP Research & Development | Option exercise 10b5-1 | +2,000 | $10.60 | $21K | 142,455 |
| 2025-03-18 | Malik Fady Ibraham EVP Research & Development | Sale 10b5-1 | −2,000 | $43.58 | $87K | 140,455 |
| 2025-03-18 | Malik Fady Ibraham EVP Research & Development | Option exercise · Non-Qualified Stock Option (Right to Buy) 10b5-1 | −2,000 | 29,105 | ||
| 2025-03-14 | Lee Sung EVP, Chief Financial Officer | Grant or award | +32,687 | 74,442 | ||
| 2025-03-14 | Lee Sung EVP, Chief Financial Officer | Grant or award · Incentive Stock Option (Right to Buy) | +9,016 | 9,016 | ||
| 2025-03-14 | Lee Sung EVP, Chief Financial Officer | Grant or award · Non-Qualified Stock Option (Right to Buy) | +41,326 | 41,326 |
Page 21 of 22 · 429 trades